Tag: ORBITA

In some cases, we are not doing PCI in the right patients

 “The real question is: who should get percutaneous coronary intervention (PCI)? I do not believe ...

EuroPCR 2018: FFR-guided PCI reduces spontaneous myocardial infarction

Five-year data from FAME (Fractional Flow Reserve vs. Angioplasty for Multivessel Evaluation) 2 ...

EuroPCR 2018: New ORBITA analysis finds iFR/FFR values do not predict impact of PCI on exercise time

New data from the ORBITA trial indicates percutaneous coronary intervention (PCI) does not signi...

Justin Davies

Justin Davies (Imperial College London, London, UK) has always been interested in computer progr...

Cardiovascular News Issue 48—March 2018 US edition

In this edition of Cardiovascular News (issue 48, US edition), we report on the top stories from TCT...

Cardiovascular News Issue 48—March 2018

In this edition of Cardiovascular News (issue 48), we report on the top stories from TCT 2017—includ...

TCT 2017: FAME 2 provides support for PCI in stable disease after ORBITA

Following ORBITA, which indicated percutaneous coronary intervention (PCI) did not provide benef...

Interventional cardiology in the Twitterverse

The past few years has witnessed increasing clinician engagement with social media platforms, in...

A bold new study could alter the orbit of elective PCI

The ORBITA (Objective randomised blinded investigation with optimal medical therapy of angioplas...

TCT 2017: Sham-controlled trial raises doubts about benefit of angiography-guided PCI for stable angina

ORBITA (Objective randomised blinded investigation with optimal medical therapy of angioplasty i...